Clinical trial
Randomized Phase III Trial of Topotecan and Cisplatin Versus Etoposide and Carboplatin in the Treatment of Patients With Previously Untreated Small Cell Lung Cancer and Extensive Disease
NCT00812266 is registered in ClinicalTrials.gov with Danish Oncological Lung Cancer Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Phase III Trial of Topotecan and Cisplatin Versus Etoposide and Carboplatin in the Treatment of Patients With Previously Untreated Small Cell Lung Cancer and Extensive Disease
- Lead sponsor
- Danish Oncological Lung Cancer Group
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- January 31, 2006
- Completion date
- January 31, 2015
- Enrollment
- 281 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
extensive disease, first-line, small cell lung cancer